Andrea S. Blevins Primeau, PhD, MBA, Author at Oncology Nurse Advisor

Andrea S. Blevins Primeau, PhD, MBA, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com Sat, 14 Oct 2023 02:37:32 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Andrea S. Blevins Primeau, PhD, MBA, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com 32 32 Mobocertinib May Meet Unmet Need in Non-Small Cell Lung Cancer https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/nsclc-lung-cancer-mobocertinib-unmet-treatment-risk/ Tue, 26 Oct 2021 13:00:00 +0000 https://www.oncologynurseadvisor.com/?p=95722 Doctors looking at tablet.

In the platinum-pretreated cohort, the objective response rate was 28%.]]> Registry Data Suggest TaTME Is Safe and Effective for Rectal Cancer https://www.oncologynurseadvisor.com/home/cancer-types/gastrointestinal-cancer/tatme-rectal-cancer-safe-effective/ Thu, 16 Sep 2021 12:00:00 +0000 https://www.oncologynurseadvisor.com/?p=94924 Surgeons

The 2-year actuarial rate of local recurrence was 4.8%.]]> Most Hospitals Surveyed Did Not Have ‘Lifesaving’ Drug for Acute Promyelocytic Leukemia https://www.oncologynurseadvisor.com/home/cancer-types/hematologic-cancers/acute-promyelocytic-leukemia-lifesaving-drug-hospitals/ Wed, 01 Sep 2021 16:20:00 +0000 https://www.oncologynurseadvisor.com/?p=94630 Hand holding drug

Thirty-one percent of hospitals had ATRA immediately available.]]> Liver Metastases Linked to Immunotherapy Resistance in Microsatellite Stable Colorectal Cancer https://www.oncologynurseadvisor.com/home/cancer-types/colorectal-cancer/colorectal-cancer-liver-metastases-immunotherapy-resistance-risk/ Fri, 20 Aug 2021 11:00:00 +0000 https://www.oncologynurseadvisor.com/?p=94303

Patients with liver metastases did not respond to checkpoint inhibitors. ]]> Model More Accurately Predicts Outcomes of Radiotherapy in Cancer Patients https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/cancer-genomic-radiation-dose-model-accurate-prediction-outcome/ Thu, 19 Aug 2021 12:00:00 +0000 https://www.oncologynurseadvisor.com/?p=94255

The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy. ]]> Avelumab Provides No Benefit as Frontline Therapy or Maintenance in Ovarian Cancer https://www.oncologynurseadvisor.com/home/cancer-types/gynecologic-cancer/ovarian-cancer-frontline-therapy-avelumab-no-benefit-risk/ Thu, 19 Aug 2021 11:00:00 +0000 https://www.oncologynurseadvisor.com/?p=94305

Avelumab did not improve progression-free survival when given concurrently with chemotherapy or as maintenance. ]]> Cervical Cancer Incidence Predicted to Decrease or Remain Stable in Many Countries https://www.oncologynurseadvisor.com/home/cancer-types/cervical-cancer/cervical-cancer-incidence-decrease-remain-stable-many-countries/ Mon, 16 Aug 2021 11:00:00 +0000 https://www.oncologynurseadvisor.com/?p=94187 Not only may co-testing help detect more cases of invasive cervical cancer, but it also may lower ov

Not only may co-testing help detect more cases of invasive cervical cancer, but it also may lower ov

Researchers analyzed recent trends in cervical cancer incidence and mortality and made predictions for the next 15 years.]]> TVUS ET Screening Misses More Cases of Endometrial Cancer in Black Women Than in White Women https://www.oncologynurseadvisor.com/home/cancer-types/gynecologic-cancer/black-women-endometrial-cancer-tvus-et-screening-treatment-risk/ Fri, 30 Jul 2021 11:00:00 +0000 https://www.oncologynurseadvisor.com/?p=93772 Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.

Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.

The disparity is due to the greater prevalence of fibroids and nonendometrioid histologic type in Black women, according to researchers.]]> Floxacin Antibiotics May Augment Treatment of Lung and Bladder Cancers by Inhibiting RSK4 https://www.oncologynurseadvisor.com/home/cancer-types/lung-cancer/lung-bladder-cancer-floxacin-rsk4-chemotherapy-antibiotic-treatment-risk/ Thu, 29 Jul 2021 13:00:00 +0000 https://www.oncologynurseadvisor.com/?p=93732 The future of chemotherapy-based options for patients with HER2-negative MBC is evolving, with emerg

The future of chemotherapy-based options for patients with HER2-negative MBC is evolving, with emerg

RSK4-targeting floxacins could boost the efficacy of chemotherapy.]]> Solid Organ Transplant Linked to Reduced Overall Survival, Not Cancer-Specific Survival https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/solid-organ-transplant-cancer-specific-survival-link-reduced-survival/ Tue, 27 Jul 2021 14:03:28 +0000 https://www.oncologynurseadvisor.com/?p=93658 Doctor talking to patient.

The findings support current management strategies for cancer patients, according to researchers.]]>